Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNLS Pharmaceutics AG Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
NLS Pharmaceutics AG Earnings Date And Information
NLS Pharmaceutics AG last posted its earnings results on Saturday, December 30th, 2023. The company reported $-0.00014 earnings per share for the quarter, topping analysts' consensus estimates of $-8.4 by $8.39986. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NLS Pharmaceutics AG has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -37.41. NLS Pharmaceutics AG has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
NLS Pharmaceutics AG Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/18/2024 | Q2 2024 | $0.00 | $0 | $0 | ||
| 05/15/2024 | Q4 2023 | -$0.14 | $0 | $0 | ||
| 06/29/2023 | Q2 2023 | -$6.80 | -$0.20 | 6.6 | $0 | |
| 05/05/2023 | Q4 2022 | -$0.29 | $0 | |||
| 10/11/2022 | Q2 2022 | -$0.54 | $0 | |||
| 03/24/2022 | Q4 2021 | -$13.80 | -$0.50 | 13.3 | $0 | |
| 09/28/2021 | Q2 2021 | -$0.42 | $0 | |||
| 05/14/2021 | Q4 2020 | -$6.80 | -$0.34 | 6.46 | $0 | |
| 06/29/2020 | Q2 2020 | -$0.11 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.18 | $0 | |||
| 06/29/2019 | Q2 2019 | -$0.31 | $0 | |||
| 12/30/2018 | Q4 2018 | -$0.28 | $0 | |||
| 06/29/2018 | Q2 2018 | -$0.19 | $0 | |||
| 03/30/2018 | Q1 2018 | -$0.12 | $0 | |||
| 06/29/2017 | Q2 2017 | -$0.16 | $0 | |||
| 03/30/2017 | Q1 2017 | -$0.16 | $0 |
NLS Pharmaceutics AG Earnings: FAQ's
When is NLS Pharmaceutics AG's earnings date?
NLS Pharmaceutics AG has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
Did NLS Pharmaceutics AG beat their earnings estimates last
quarter?
In the previous quarter, NLS Pharmaceutics AG (:NLSP) reported $-0.00014 earnings per share (EPS) to beat the analysts' consensus estimate of $-8.4 by $8.39986.
How can I listen to NLS Pharmaceutics AG's earnings conference
call?
The conference call for NLS Pharmaceutics AG's latest earnings report can be listened to online.
How can I read NLS Pharmaceutics AG's conference call transcript?
The conference call transcript for NLS Pharmaceutics AG's latest earnings report can be read online.
How much profit does NLS Pharmaceutics AG generate each year?
NLS Pharmaceutics AG (:NLSP) has a recorded net income of $0. NLS Pharmaceutics AG has generated $-0.32 earnings per share over the last four quarters.
What is NLS Pharmaceutics AG's price-to-earnings ratio?
NLS Pharmaceutics AG (:NLSP) has a price-to-earnings ratio of -37.41 and price/earnings-to-growth ratio is -0.37.